Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Elderly Newly Diagnosed AML
NCT00373373Phase 2Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Sep 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in acute myeloid leukemia (AML), sponsored by Universitätsklinikum Münster. Started Sep 2006; status: completed.
02
Drugs
sorafenib
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00373373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373373.